Navigation Links
Fero Industries Signs First Sucanon® Distribution Agreement for the Middle East
Date:10/5/2011

CALGARY, Canada, Oct. 5, 2011 /PRNewswire/ -- Fero Industries, Inc. (OTCQB: FROI) is pleased to announce that it has entered into an exclusive Distribution Agreement with Behestan Behdasht (P.J.S.) ("Behestan") for the marketing and distribution of Sucanon® within the country of Iran.

The Distribution Agreement calls for a minimum purchase of US$11 million over a period of 4 years and gives Behestan the exclusive right to market and sell Sucanon® through its established distribution channels in Iran.  The agreement requires a minimum order of 250,000 retail packages of Sucanon® during Year 1, increasing to a minimum of 1,450,000 retail packages during Year 4.  

Behestan is expected to immediately begin the regulatory process with the Ministry of Health and Medical Education (MOHME) required for the sale of Sucanon® in Iran, while Fero will be responsible for acquiring the required humanitarian exemption from the U.S. Treasury Departments' Office of Foreign Asset Control.  The companies expect that the licensing process will be completed and the first shipment of Sucanon® will commence within 180 days.  

"The rapid increase in the number of people in the Middle East with type-2 diabetes is a direct indicator of the need for Sucanon® in the region and we are fortunate to have aligned ourselves with a company of Behestan's caliber to lead the product launch in Iran," said Mr. Luis Lopez, President and COO of Fero Industries.  "Behestan's local business and consumer knowledge along with their established pharmaceutical and healthcare products distribution channels make them an ideal partner.  We intend to expand this business model across the Middle East."

Iran and other countries in the Middle East have one of the largest and fastest growing diabetic populations in the world.  Six countries in the Middle East and North African Region rank among the world's top ten for diabet
'/>"/>

SOURCE Fero Industries, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM)
2. Prix Galien USA Honors Innovation in Science and Biotech Industries
3. Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
4. Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses
5. Roper Industries Schedules Fourth Quarter 2009 Financial Results Conference Call
6. Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest
7. Roper Industries Completes the Acquisition of Verathon, Inc.
8. Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest and Conversion Rate Adjustment
9. SL Industries Names Louis J. Belardi Chief Financial Officer
10. Newly Re-launched Website Helps PhDs and MDs Capitalize on Growth in Life Science Industries
11. iGPS Announces iGPS bios™, a New Pallet Rental Service Designed Exclusively for the Pharmaceutical and Life Sciences Industries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, ... Global Biotechnology, Inc. for the compounding, packaging and distributing of ... in the United States . ... capable of compounding naltrexone tablets in various strengths for individual ...
(Date:1/23/2015)... Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself ... share and grab a foothold in the hydroponic, hemp and ... and a presence in the sector, and recently partnering with ... of hemp and medical marijuana, iMD is committing to bring ...
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... Clinical Trials for Organ Transplantation, HORSHOLM, Denmark, May ... I clinical results for,its transplantation product candidate, LCP-Tacro ... organ transplantation. , Today LifeCycle Pharma A/S (OMX:LCP) ... program of LCP-Tacro, a,proprietary, once-daily tacrolimus tablet. , ...
... at the Pediatric Academic Societies' Annual Meeting,This Month ... Pulse,Oximetry Technology Can Reduce the Risk Associated with ... /PRNewswire/ -- Masimo, the,inventor of Pulse CO-Oximetry and ... a new independent study,presented at the Pediatric Academic ...
Cached Medicine Technology:LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 2LifeCycle Pharma Announces Positive Phase I Clinical Results for,its Transplantation Product Candidate, LCP-Tacro 3Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 2Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 3Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology,Shown to Significantly Lower Instances of Severe Retinopathy of,Prematurity in Extremely Low Birth Weight Infants 4
(Date:1/22/2015)... (PRWEB) January 23, 2015 VogueQueen is a ... affordable prices and many designers are thrilled to have it ... business announces its new collection of prom dresses for the ... to drive the strategic vision and he focuses on continuing ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The federal court ... the U.S. District Court, Southern District of West Virginia has ... in that proceeding’s first bellwether trial. In an Order dated ... new trial after finding that C.R. Bard had not proven ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... a common side effect- cough. Iron supplementation cures the ... blood pressure medication. , The angiotensin-converting enzyme (ACE) inhibitors ... failure and other cardiac conditions. But up to 40% ... cough. The side effect is not considered serious by ...
... in Germany have developed a new risk assessment methodology ... patient's risk of cardiac death. , ECG is the ... can be determined and analysed by the computer.The time ... be calculated.// When the programme has completed its analysis, ...
... starch, previously thought to be just 'empty calories', actually helps ... Organisation (CSIRO), researchers have revealed that resistant starch could be ... , , ... China have low rates of bowel cancer even though they ...
... small amounts of alcohol consumption is linked with deliquent ... new study. ,Dr. Virginia Delaney-Black, of Children's Hospital ... out with the finding that in comparison to the ... a week during pregnancy were three times more likely ...
... slimming FDA approved drug which can actually works. Not only that ... slimming. This wonder slimming drug is XENICAL. ,Xenical allows ... pass through the gut undigested. Your body cannot convert these excess ... energy. This will therfore help you to reduce your weight, maintain ...
... biopsy detecting technique for prostate cancers has been found out ... traditional examination. In the traditional exam for prostate cancer, the ... , At Ohio State University, researchers said that it is ... team, called this the extended sector biopsy. They ...
Cached Medicine News:
Finger /Thumb Splint has a stay that may be shaped to hold finger or thumb in exact degree of flexion. It also has a contact closure....
Combination Oppenheimer with Knuckle Bender - to dorsiflex wrist and flex MCP joints; includes two attachments to extend/flex distal finger joints....
Bunell Mini-Modified Safety Finger Pin reduces PIP flexion contractures....
... Slings makes dynamic splinting easier and ... slings fit every splinting need. Non-slip ... on the distal phalanx. One size ... of 10 and 25. FoamWrap™ splints ...
Medicine Products: